The chemotactic activity of normal and diluted human serum and plasma for human monocytes and neutrophils was investigated. Undiluted, neither serum nor plasma attract monocytes, but this is attributable to an inhibitor masking chemotactic activity. When diluted 3- to 100-fold, appreciable activity for monocyte is detected. In contrast, chemotactic activity for neutrophils is already demonstrable in undiluted normal serum. Chemotactic activities are heat-labile, behave as pseudoglobulins, do not pass through a Diaflo PM 30 membrane and are not inactivated by treatment with di-isopropylfluorophosphate. They seem to be unrelated to the recognized components (or split products) of complement, kallikrein formation, clotting, fibrinolysis or isoantibody-blood cell-complement interaction. Upon complement activation of serum, neutrophil and monocyte chemotactic activities were generated which differed in several respects from the normal serum activities. The relative increase in activity upon activation of serum compared with normal serum was generally high for neutrophils but low for monocytes.

This content is only available via PDF.
© 1977 S. Karger AG, Basel
1977
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.